Kathy Giusti
Showing 1–2 of 2 transcripts.
- Milken Institute58 min
Redefining Philanthropic Drug Discovery
Emma Court, Bob Crutchfield, Kathy Giusti, John Rigg, Todd Sherer
Representative non-profits including the Multiple Myeloma Research Foundation, American Cancer Society, and Michael J. Fox Foundation are deploying specialized venture funds and pre-competitive consortia to accelerate drug development through strategic data ownership and direct investment. These entities face significant structural challenges regarding talent acquisition, donor reluctance to forgo financial returns, and the lack of viable reimbursement models for critical areas like antimicrobial stewardship. Panelists recommend that organizations conduct rigorous landscape assessments and adopt neutral, execution-focused investment strategies to bridge the gap between philanthropy and commercial innovation without crowding out private sector growth.
- Milken Institute1h 14m
Sustaining the New 'Golden Age' of Medical Research
Margaret Anderson, Francis Collins, Kathy Giusti, Michael Milken, Kevin Yoder, Elias Zerhouni
At the 19th annual Milken Institute Global Conference, leaders including Kathy Hudson, Elias Zerhouni, and Francis Collins convened to address systemic inefficiencies in biomedical research while celebrating unprecedented therapeutic breakthroughs. The panelists emphasized that stagnant NIH funding and a 16% grant success rate threaten the scientific pipeline, yet initiatives like the Precision Medicine Initiative and Accelerating Medicine Partnerships are introducing parallel processing and open data models to accelerate cures. By reframing research as a national security priority and integrating artificial intelligence, these experts argue that coordinated public-private ecosystems can overcome current bottlenecks to deliver transformative medical advancements.